MENU
SYBX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Synlogic (SYBX) Ownership - Who owns Synlogic?
Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU)... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
301 Binney Street
Phone
+1 617 401-9975
Employees
6
Web
https://www.synlogictx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
14.04M
P/E Ratio
N/A
Total Cash
18.86M
Projected Growth
N/A
Total Debt
N/A
Revenue
8K
Risk (Beta)
0.59
Dividend Yield
N/A
Total Cash/Share
1.61
Total Debt/Equity
N/A
Revenue/Share
0.00 USD as % of share price
Fundamentals
SYBX
Capitalization
14M
P/E Ratio
N/A
Risk (Beta)
0.59
Dividend Yield
N/A
Total Cash
18.9M
Total Cash/Share
1.61
Total Debt
0
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.00%
Revenue
8K
ROE
N/A
Book Value
12.8M
P/B Ratio
1.10
Cash Flow
N/A
Earnings
-1.92
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
12K
Current Ratio
2.80
Current Revenue Per Employee
1333.33
Dividends Per Share - Security
N/A
EBITDA
-23.01M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-48.98
Shares Held By Institutions
10M
Shares Outstanding - Current
11.7M
Total Liabilities
7.08M
Total Volume MTD
N/A
Value
-1
Gain YTD
-12.857
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of biopharmaceuticals
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
301 Binney Street
Phone
+1 617 401-9975
Employees
6
Web
https://www.synlogictx.com